Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 83, 2023 - Issue 3
Submit an article Journal homepage
120
Views
1
CrossRef citations to date
0
Altmetric
Articles

Potential interference of in vitro carbamylation on C-reactive protein laboratory measurement

Carolina dos Santos Steina Laboratory of Clinical Biochemistry, Department of Clinical and Toxicological Analysis, Center of Health Sciences, Federal University of Santa Maria, Santa Maria, Brazil;b Graduate Program in Pharmaceutical Sciences, Center of Health Sciences, Federal University of Santa Maria, Santa Maria, BrazilORCID Iconhttps://orcid.org/0000-0001-5920-4831View further author information
ORCID Icon,
José Pedro Etchepare Cassola Laboratory of Clinical Biochemistry, Department of Clinical and Toxicological Analysis, Center of Health Sciences, Federal University of Santa Maria, Santa Maria, BrazilORCID Iconhttps://orcid.org/0000-0003-4728-3872View further author information
ORCID Icon &
Rafael Noal Morescoa Laboratory of Clinical Biochemistry, Department of Clinical and Toxicological Analysis, Center of Health Sciences, Federal University of Santa Maria, Santa Maria, Brazil;b Graduate Program in Pharmaceutical Sciences, Center of Health Sciences, Federal University of Santa Maria, Santa Maria, BrazilCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3072-5080View further author information
ORCID Icon
Pages 183-186 | Received 14 Dec 2022, Accepted 12 Mar 2023, Published online: 04 Apr 2023

References

  • Delanghe S, Delanghe JR, Speeckaert R, et al. Mechanisms and consequences of carbamoylation. Nat Rev Nephrol. 2017;13(9):580–593.
  • Gillery P, Jaisson S. Post-translational modification derived products (PTMDPs): toxins in chronic diseases? Clin Chem Lab Med. 2014;52(1):33–38.
  • Wang Z, Nicholls SJ, Rodriguez ER, et al. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med. 2007;13(10):1176–1184.
  • Pattison DI, Davies MJ, Hawkins CL. Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypochlorous and hypothiocyanous acids. Free Radic Res. 2012;46(8):975–995.
  • Rapa SF, Di Iorio BR, Campiglia P, et al. Inflammation and oxidative stress in chronic kidney disease—potential therapeutic role of minerals, vitamins and plant-derived metabolites. IJMS. 2019;21(1):263.
  • Shi J, van Veelen PA, Mahler M, et al. Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies. Autoimmun Rev. 2014;13(3):225–230.
  • Binder V, Bergum B, Jaisson S, et al. Impact of fibrinogen carbamylation on fibrin clot formation and stability. Thromb Haemost. 2017;117(5):899–910.
  • Holzer M, Gauster M, Pfeifer T, et al. Protein carbamylation renders high-density lipoprotein dysfunctional. Antioxid Redox Signal. 2011;14(12):2337–2346.
  • Doué M, Okwieka A, Berquand A, et al. Carbamylation of elastic fibers is a molecular substratum of aortic stiffness. Sci Rep. 2021;11(1):17827.
  • Du Clos TW. Function of C-reactive protein. Ann Med. 2000;32(4):274–278.
  • Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.
  • Ortega O, Rodriguez I, Gallar P, et al. Significance of high C-reactive protein levels in pre-dialysis patients. Nephrol Dial Transplant. 2002;17(6):1105–1109.
  • Ansar W, Ghosh S. C-reactive protein and the biology of disease. Immunol Res. 2013;56(1):131–142.
  • Cassol JPE, Scolari R, Moresco RN. Impact of albumin carbamylation on immunoturbidimetric measurement of urinary albumin. Anal Biochem. 2021;614:114047.
  • Kok MB, Tegelaers FPW, van Dam B, et al. Carbamylation of albumin is a cause for discrepancies between albumin assays. Clin Chim Acta. 2014;434:6–10.
  • Potempa LA, Maldonado BA, Laurent P, et al. Antigenic, electrophoretic and binding alterations of human C-reactive protein modified selectively in the absence of calcium. Mol Immunol. 1983;20(11):1165–1175.
  • Seki M, Nakayama M, Sakoh T, et al. Blood urea nitrogen is independently associated with renal outcomes in japanese patients with stage 3–5 chronic kidney disease: a prospective observational study. BMC Nephrol. 2019;20(1):115.
  • Koshiishi I, Imanari T. State analysis of endogenous cyanate ion in human plasma. J Pharmacobiodyn. 1990;13(4):254–258.
  • Fu EL, Franko MA, Obergfell A, et al. High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post–myocardial infarction patients. Am Heart J. 2019;216:20–29.
  • Bazeley J, Bieber B, Li Y, et al. C-Reactive protein and prediction of 1-Year mortality in prevalent hemodialysis patients. CJASN. 2011;6(10):2452–2461.
  • Cassol JPE, Moresco RN. Impact of albumin carbamylation on colorimetric measurement of albumin. Clin Lab. 2022;68(6):1302–1304.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.